The role of allergy in sinus disease: Children and adults

Clinical Reviews in Allergy and Immunology

Volumn 16, Issue 1-2, 1998, Pages 55-156

  Pelikan, Zdenek ^a  

^a Medisch Centrum de Klokkenberg   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ALIMEMAZINE; ALIMEMAZINE TARTRATE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; CINNARIZINE; CLEMASTINE; CLEMASTINE FUMARATE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYPROHEPTADINE; DEXCHLORPHENIRAMINE; DEXCHLORPHENIRAMINE MALEATE; DIMETINDENE; FLUNISOLIDE; FLUTICASONE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; KETOTIFEN FUMARATE; LEVOCABASTINE; LORATADINE; MEBHYDROLIN; MEQUITAZINE; METHYRIT; NEDOCROMIL; PROMETHAZINE; TERFENADINE; TIXOCORTOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIARIN;

ALLERGY; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; IMMUNOPATHOLOGY; NOSE SECRETION; REVIEW; SINUSITIS;

EID: 0031865766     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739328     Document Type: Review

References (243)

1. Slavin RG. Sinusitis in adults. J Allergy Clin Immunol 1988;81:1028-1032.
2. English GM. Nasal polyps and sinusitis. In: Middleton E Jr, Reed CE, Ellis EF, eds., Allergy, Principles and Practice, 2nd ed. St. Louis, MO: CV Mosby, 1983; pp. 1215-1248.
3. Wald ER. Microbiology of acute and chronic sinusitis. Immunol Allergy Clin N Am 1994;14(No 1):31-45.
4. Ballenger JJ, Harding HB. Paranasal sinus infection. In: Ballenger JJ, ed., Diseases of the Nose, Throat and Ear, 12th ed. Philadelphia: Lea & Febiger, 1977; pp. 155-167.
5. White JA. Paranasal sinus infections. In: Ballenger JJ, ed. Diseases of the Nose, Throat, Ear, Head and Neck, 14th ed. Philadelphia: Lea & Febiger, 1991; pp. 184-202.
6. Slavin RG. Nasal polyps and sinusitis. In: Middleton E, Reed ChE, Ellis EF, Adkinson EF, Yunginger JW, Busse WW, eds., Allergy, Principles and Practice, 4th ed. St. Louis, MO: Mosby-Year Book, 1993; pp. 1455-1470.
7. Fireman P. Diagnosis of sinusitis in children: emphasis on the history and physical examination. J Allergy Clin Immunol 1992;90(No 3, Part 2):433-436.
8. Shapiro GG. Sinusitis in children. J Allergy Clin Immunol 1988;81:1025-1027.
9. Rachelefsky GS, Siegel SC, Katz RM, Spector MD, Rohr AS. Chronic sinusitis in children (abstract). J Allergy Clin Immunol 1991;87:219.
10. Middleton E Jr. Chronic rhinitis in adults. J Allergy Clin Immunol 1988;81:971-975.
11. Rachelefsky GS, Katz RM, Siegel SC. Chronic sinusitis in children with respiratory allergy: the role of antimicrobials. J Allergy Clin Immunol 1982;69:382-387.
12. Pearlman DS. Chronic rhinitis in children. J Allergy Clin Immunol 1988;81: 962-966.
13. Harlin SL, Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:867-875.
14. Kuhn JP. Imaging of the paranasal sinuses: current status. J Allergy Clin Immunol 1986;77:6-8.
15. Lober P. Histology and pathology of the nose and sinuses. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 1. Philadelphia: WB Saunders 1973; 551-562.
16. Aust R. Oxygen exchange through the maxillary ostium in man. Rhinology 1974;12:25-37.
17. 2 tension in the maxillary sinuses. Rhinology 1976;14:43,44.
18. Rohr AS, Spector SL. Paranasal sinus anatomy and pathophysiology. Clin Rev Allergy 1984;2:387-395.
19. Graney DO. Anatomy of the paranasal sinuses. Immunol Allergy Clin N Am 1994;14(No 1):1-15.
20. Mann W, Beck C, Apostolidis T. Liability of ultrasound in maxillary sinus disease. Arch Otorhinolaryngol 1972;215:67-74.
21. Revonta M. Ultrasound in the diagnosis of maxillary and frontal sinusitis. Acta Otolaryngol 1980;370(suppl):1-54.
22. Jannert M, Andreasson L, Holmer N-G. Ultrasonic examination of the paranasal sinuses. Acta Otolaryngol 1982;389(suppl):1-51.
23. Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME. Functional endoscopic sinus surgery. Arch Otolaryngol 1985;111:576-582.
24. Stammberger H. Endoscopic endonasal surgery - concepts in treatment of recurring rhinosinusitis. Part 1. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg 1986;94:143-147.
25. Bolger WE, Butzin CA, Parsons DS. Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope 1991;101:56-64.
26. Laszlo I. Radiology of the paranasal sinuses. In: Ballenger JJ, ed. Diseases of the Nose, Throat and Ear, 12th ed. Philadelphia: Lea & Febiger 1977; pp. 155-167.
27. Zizmor J, Noyek AM. Radiology of the nose and paranasal sinuses. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 1. Philadelphia: WB Saunders, 1983; pp. 1043-1095.
28. Shapiro GG, Furukawa CT, Pierson WE, Gilbertson E, Bierman CW. Blinded comparison of maxillary sinus radiography and ultrasound for diagnosis of sinusitis. J Allergy Clin Immunol 1986;77:59-64.
29. Landman MD. Ultrasound screening for sinus diseases. Otolaryngol Head Neck Surg 1986;94:157-164.
30. Druce HM. Diagnosis of sinusitis in adults: History, physical examination, nasal cytology, echo, and rhinoscope. J Allergy Clin Immunol 1992;90(No 3, Part 2):436-441.
31. Diament MJ. The diagnosis of sinusitis in infants and children: X-ray, computed tomography, and magnetic resonance imaging. J Allergy Clin Immunol 1992;90 (No 3, Part 2):442-444.
32. Lusk RP. Endoscopic approach to sinus disease. J Allergy Clin Immunol 1992;90(No 3, Part 2):496-505.
33. Zinreich J. Imaging of inflammatory sinus disease. Immunol Allergy Clin N Am 1994;14(No 1):17-29.
34. Friedman WH, Slavin RG. Diagnosis and medical and surgical treatment of sinusitis in adults. Clin Rev Allergy 1984;2:409-428.
35. Williams HL. Infections and granulomas of the nasal airways and paranasal sinuses. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 3, Philadelphia: WB Saunders, 1973; pp. 27-38.
36. Steiner D, Feehs K, Georgitis JW. Immunodeficiency in children with recurrent sinusitis and otitis (abstract). J Allergy Clin Immunol 1989;83:276.
37. Goodman GM, Slavin RG. Medical management in adults. Immunol Allergy Clin N Am 1994;14(No 1):69-87.
38. Williams HL. Nasal physiology. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 1. Philadelphia: WB Saunders, 1973; pp. 329-346.
39. Slavin RG. Clinical disorders of the nose and their relationship to allergy. Ann Allergy 1982;49:123-126.
40. Slavin RG, Zilliox AP, Samuels LD. Allergic sinusitis: does it exist? (abstract) N Engl Reg Allergy Proc 1988;9:253.
41. Slavin RG, Zilliox AP, Samuels LD. Is there such an entity as allergic sinusitis? J Allergy Clin Immunol 1988;81:284(abstract No 466).
42. Furukawa CT. The role of allergy in sinus in children. J Allergy Clin Immunol 1992;90(No 3, Part 2):515-517.
43. Spector SL. The role of allergy in sinus in adults. J Allergy Clin Immunol 1992;90(No 3, Part 2):518-520.
44. Holmström M, Lund VJ, Scadding G. Nasal ciliary beat frequency after nasal allergen challenge. Am J Rhinol 1992;6:101-105.
45. Schapiro GG, Virant FS. Medical management in children. Immunol Allergy Clin N Am 1994;14(No 1):47-68.
46. Minotti DA. Allergic rhinitis and sinusitis. Immunol Allergy Clin N Am 1994;14(No 1):113-127.
47. Pinczower EF, Weymuller EA. Nasal obstruction. Immunol Allergy Clin N Am 1994;14(No 1):129-142.
48. Shapiro GG. Role of allergy in sinusitis. Pediatr Infect Dis 1985;4:55-58.
49. Fusijawa T, Kephart GM, Gray BH, Gleich GJ. The neutrophil and chronic allergic inflammation. Immunochemical localization of neutrophil elastase. Am Rev Respir Dis 1990;141:689-697.
50. Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy 1989;44:116-122.
51. Jeney GR, Meredith S, Baraniuk J, Kaliner M. Nasal secretions in recurrent sinusitis (abstract). J Allergy Clin Immunol 1989;83:214.
52. Sacha RF, Trembray NF, Jacobs RL. Chronic cough, sinusitis, and hyperreactive airways in children: an overlooked association. Ann Allergy 1985;54:195-198.
53. Pelikan Z. Nasal challenge with allergen (NPT) in patients with chronic sinusitis maxillaris (abstract 018). N Engl Reg Allergy Proc 1988;9:253.
54. Pelikan Z. Role of nasal allergy in chronic sinusitis maxillaris (CSM) - diagnostic value of nasal challenge with allergen (NPT). J Allergy Clin Immunol 1989;83(No 1):214(abstract 171).
55. Pelikan Z. Chronic sinusitis maxillaris (CSM) and nasal allergy - comparison of the echography and radiographs during the nasal challenge with allergen (NPT). Proceedings of the 13th Congress of European Rhinologic Society, incl. the IXth ISIAN & combined with BSACI & EAFS, London, June 24-29, 1990;225.
56. Pelikan Z, Pelikan-Filipek M. Role of nasal allergy in chronic maxillary sinusitis - diagnostic value of nasal challenge with allergen. J Allergy Clin Immunol 1990;86:484-991.
57. Pelikan Z, Pelikan-Filipek M. The role of nasal allergy in chronic sinusitis maxillaris (CSM) - X-ray and echography during the nasal response to allergen challenge. Allergy Clin Immunol News 1991(suppl 1);334(abstract 933).
58. Pelikan Z, Pelikan-Filipek M, Ossekoppele R. Chronic sinusitis maxillaris (CSM) - the role of nasal allergy and the diagnostic value of echography and radiographs. Allergy Clin Immunol News 1994(suppl 2);415(abstract 1500).
59. Pelikan Z, Pelikan-Filipek M, van Stigt HJ. The maxillary sinus (MS) response due to the food allergy. J Allergy Clin Immunol 1995;95(No 1, Part 2):328 (abstract 750).
60. Wagenmann M, Naclerio RM. Anatomic and physiologic considerations in sinusitis. J Allergy Clin Immunol 1992;90(No 3, Part 2):419-423.
61. Rachelefsky GS, Golbert M, Katz RM, Boris G, Gyepes MT, Shapiro MJ, Mickey MR, Finegold SM, Siegel SC. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1978;61:310-314.
62. Melen I, Ivarsson A, Schrewelins C. Ostial function in allergic rhinitis. Acta Otolaryngol (Stockh) 1992;492(suppl):82-85.
63. Pelikan Z. Late nasal response to allergen challenge (LNR) - clinical features and pharmacologic modulation. Proceedings of the 13th Congress of European Rhinologic Society, incl. the IXth ISIAN & combined with BSACI & EAFS, London, June 24-29, 1990;226.
64. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy 1978;41:37-47.
65. Pelikan Z. The role of immediate, late and delayed reactions in allergic nasal diseases. In: Pepys J, Edwards AM, eds. The Mast Cell, Its Role in Health and Disease. Tunbridge Wells: Pitman Medical Publ, 1979; pp. 772-777.
66. Pelikan Z. Late nasal response - its clinical characteristics, features, and possible mechanisms. In: Dorsch W, ed. Late Phase Allergic Reactions. Boca Raton, FL; CRC, 1990; pp. 111-155.
67. th International Congress of mucosal Immunology, Prague, Czechoslovakia, August 16-20, 1992;185.
68. Pelikan Z, Feenstra L, Barree GOF. Response of the nasal mucosa to allergen challenge measured by two different methods of rhinomanometry. Ann Allergy 1977;38:263-267.
69. Pelikan Z, Pelikan-Filipek M. The diagnostic approach to the immediate hypersensitivity in patients with allergic rhinitis: a comparison of nasal challenges and serum RAST. Ann Allergy 1983;50:395-400.
70. Davies J. Embryology and anatomy of the face, palate, nose and paranasal sinuses. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 1, Philadelphia: WB Saunders 1973; pp. 150-178.
71. Kaliner MA. Human nasal host defence and sinusitis. J Allergy Clin Immunol 1992;90(No 3, Part 2):424-430.
72. Despot JE, Lemanske RF. Inflammatory mediators in allergic rhinitis. Immunol Allergy Clin N Am 1987;7:37-55.
73. Shearer WT, Huston DP. The immune system. In: Middleton E, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St Louis, MO: Mosby-Year Book, 1993; pp. 3-21.
74. Siraganian RP. Mechanism of IgE-mediated hypersensitivity. In: Middleton E, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St. Louis, MO: Mosby-Year Book, 1993; pp. 105-134.
75. Lemanske RF, Kaliner MA. Late phase allergic reactions. In: Middleton E, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St. Louis, MO: Mosby-Year Book 1993; pp. 320-361.
76. Askenase PW. Effector and regulatory mechanisms in delayed type hypersensitivity. In: Middleton E, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St. Louis, MO: Mosby-Year Book 1993; pp. 362-389.
77. Zweiman B, Levinson AI. Cell-mediated immunity in health and disease. In: Middleton E, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St Louis, MO: Mosby-Year Book, 1993; pp. 963-989.
78. Lawley TJ, Frank MM. Immune complexes and allergic disease. In: Middleton E, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St Louis, MO: Mosby-Year Book, 1993; pp. 990-1006.
79. Goodman JW. The immune response. In: Stites DP, Terr AI, eds. Basic and Clinical Immunology, 7th ed. Norwalk, CT: Appleton & Lange, 1991; pp. 34-44.
80. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines. In: Stites DP, Terr AI, eds. Basic and Clinical Immunology, 7th ed. Norwalk, CT: Appleton & Lange, 1991; pp. 78-100.
81. Terr AI. Mechanisms of inflammation. In: Stites DP, Terr AI, eds. Basic and Clinical Immunology, 7th ed. Norwalk, CT: Appleton & Lange, 1991; pp. 131-140.
82. Coombs RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, Lachmann PJ, eds. Clinical Aspects of Immunology, 3rd ed. Oxford: Blackwell Scientific Publications, 1975; pp. 761-781.
83. Pelikan Z. Differential diagnosis of nasal hyperreactivity and allergy, in allergic rhinitis. Proceedings of the Symposium "Facts about the nose," Brugge, Nov 18, 1989, Huizing EH, ed. Astra, The Netherlands, 1991;45-53.
84. Pelikan Z. Non-specific hyperreactivity of the nasal mucosa (N-SH)-comparison of histamine and metacholine challenges in rhinitis patients. Allergy Clin Immunol News 1991;(suppl 1):335(abstract 934).
85. Pelikan Z. Allergic and non-specific hyperreactivity (N-SH) component in patients with chronic rhinitis. Allergy Clin Immunol News 1991;(suppl 1):335 (abstract 935).
86. Pelikan Z, Pelikan-Filipek M. Non-specific hyperreactivity (N-SH) and basic types of nasal response to allergen challenge in rhinitis patients. J Allergy Clin Immunol 1992;89(No 1, Part 2):179(abstract 140).
87. Pelikan Z. Provocation tests - a definitive confirmation of the role and involvement of a certain allergen or a non-specific hyperreactivity agent in the complaints of patients with an allergy disorder. Abstracts of the International Seminar on the Immunological System as a Target for Toxic Damage. (An International Seminar organized by the Commission of the European Communities, WHO and the United States Environmental Protection Agency), Luxembourg, November 6-9, 1984;122-126.
88. Pelikan Z. Immediate hypersensitivity and non-specific hyperreactivity in the nose and bronchial tree - a possible double role of the mast cells and basophils, - the place and role of the chemicals. Abstracts of the International Seminar on the Immunological System as a Target for Toxic Damage. (An International Seminar organized by the Commission of the European Communities, WHO and the United States Environmental Protection Agency), Luxembourg, November 6-9, 1984;127-130.
89. Pelikan Z. Participation of allergy (ALL) and non specific hyperreactivity [N-SH] components in rhinitis. Allergy Clin Immunol News 1994;(suppl 2):415 (abstract 1499).
90. Pelikan Z, Pelikan-Filipek M. The effects of disodium cromoglycate and beclomethasone dipropionate on the immediate response of the nasal mucosa to allergen challenge. Ann Allergy 1982;49:283-292.
91. Pelikan Z, Pelikan-Filipek M. The effects of disodium cromoglycate and beclomethasone dipropionate on the late response of the nasal mucosa to allergen challenge. Ann Allergy 1982;49:200-212.
92. Pelikan Z. The effects of disodium cromoglycate (DSCG) and beclomethasone dipropionate (BDA) on the delayed nasal mucosa response to allergen challenge. Ann Allergy 1984;52:111-124.
93. Solomon W, McLean JA. Nasal provocative testing. In: Spector SL, ed. Provocative Challenge Procedures: Background and Methodology. Mount Kisco, NY: Futura Publ, 1989; pp. 569-625.
94. 4) in the nasal secretions. Ann Allergy 1985;55:336(abstract 443).
95. Pelikan Z, Pelikan-Filipek M. A new disease - a nasal form of pigeon breeder's disease. Allergy 1983;38:309-318.
96. Pelikan Z. The changes in the nasal secretions' eosinophils during the immediate nasal response to allergen challenge. J Allergy Clin Immunol 1983;72:657-662.
97. Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretions (NS) during the immediate (ESJR) and the late nasal response (LNR) to allergen challenge. In: Nijkamp FP, Engels F, Hendrickx PAV, Oosterhout AJM, eds. Mediators in Airway Hyperreactivity. Basel, Switzerland: Birkhäuser Verlag 1990; pp. 55-62.
98. Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretions during the late nasal response. J Allergy Clin Immunol 1989;83:1068-1079.
99. Pelikan Z, Pelikan-Filipek M. Cytological changes in the nasal secretions during the immediate nasal response. J Allergy Clin Immunol 1988;82:1103-1112.
100. Pelikan Z. Rhinitis and secretory otitis media: a possible role of food allergy. In: Brostoff J, Challacombe SJ, eds. Food Allergy and Intolerance. London: Baillière Tindall, Sanders, 1987; pp. 467-485.
101. Pelikan Z, Pelikan-Filipek M. Nasal secretions (NS) cytology during the delayed nasal response to allergen challenge (DNR). Allergy Clin Immunol News 1991;(suppl 1):334(abstract 930).
102. Pelikan Z, Pelikan-Filipek M. Intracellular changes in some cell types in nasal secretions (NS) during the immediate (INR) and late (LNR) nasal response to allergen challenge. Allergy Clin Immunol News 1991;(suppl 1):273(abstract 689).
103. Pelikan-Filipek M, Pelikan Z. Histamine in nasal secretions (NS) during the immediate nasal response to allergen challenge (INR). J Allergy Clin Immunol 1992;89(No 1, Part 2):333(abstract 754).
104. Pelikan Z, Johansson S-A. Effects of Disodium cromoglycate (DSCG) and Budesonide (BSA) on the late nasal response (LNR) and nasal secretions cytology (NS). Allergy 1992;47(No 12, suppl):3(abstract).
105. Pelikan Z, Pelikan-Filipek M. The effects of disodium cromoglycate (DSCG) and Budesonide (BSA) on the immediate nasal response (INR) and nasal secretions cytology (NS). Allergy 1992;47(No 12, suppl):284(abstract).
106. Pelikan Z. Histamine (NS) in nasal secretions (NS) and its changes during the basis types of nasal response (NR) to allergen challenge. Allergy 1992;47(No 12, suppl):304(abstract).
107. Pelikan Z, Pelikan-Filipek M. Immediate nasal response to allergen challenge (INR) - cytologic changes in the nasal secretions (NS) and histologic changes in the nasal mucosa. Proceedings of the 17th International Congress of Mucosal Immunology, Prague, Czechoslovakia, August 16-20, 1992;184.
108. Johansson SA, Pelikan Z. The effects of Cromolyn (DSCG) and Budesonide (BSA) on the late nasal response (LNR), changes in the cell count in the late nasal response (LNR), changes in the cell count in the nasal secretions (NS) and their intracellular changes. J Allergy Clin Immunol 1993;91(No 1, Part 2):259 (abstract 475).
109. Pelikan-Filipek M, Pelikan Z. The effects of Cromolyn (DSCG) and Budesonide (BSA) on the immediate nasal response (INR), the appearance of cell-types in nasal secretions (NS) and their intracellular changes. J Allergy Clin Immunol 1993;91(No 1, Part 2):300(abstract 636).
110. Pelikan Z, Pelikan-Filipek M. Intracellular changes of eosinophils (EO), neutrophils (NE) and basophils (BS) in nasal secretions (NS) during the early (ENR) and late (LNR) nasal response. Allergy Clin Immunol News 1994;(suppl 2);336(abstract 1205).
111. Pelikan-Filipek M, Pelikan Z. Intracellular changes in some cell types in nasal secretions (NS) accompanying the immediate nasal response (INR). J Allergy Clin Immunol 1990;85(No 1, Part 2):300(abstract 626).
112. Pelikan Z. Intracellular changes of eosinophils, neutrophils and basophils in nasal secretions during the immediate nasal response to allergen challenge. N Engl Reg Allergy Proc 1988;9(No 4):442.
113. Pelikan-Filipek M, Pelikan Z. Nasal secretions cytology (NS) during the immediate nasal response (INR), pretreated with Disodium cromoglycate (DSCG) and Budesonide (BSA). J Allergy Clin Immunol 1991;87(No 1, Part 2):144 (abstract 24).
114. Pelikan Z, Pelikan-Filipek M. Cytologic changes in nasal secretions (NS) during the late nasal response (LNR) pretreated with disodium cromoglycate (DSCG) and beclomethasone dipropionate (BDA) or budesonide (BSA). J Allergy Clin Immunol 1991;87(No 1, Part 2):281 (abstract 566).
115. Pelikan Z. Histologic changes in the nasal mucosa during the immediate (INR), late (LAR) and delayed (DNR) nasal response to allergen challenge. Allergy Clin Immunol News 1991;(suppl 1);132(abstract 158).
116. Pelikan Z, Pelikan-Filipek M. Cytologic changes in nasal secretions (NS) during the delayed nasal response (DNR) pretreated with disodium cromoglycate (DSCG) and beclomethasone dipropionate (BDA) or budesonide (BSA). Allergy Clin Immunol News 1991;(suppl 1):334(abstract 932).
117. Walden SM, Proud D, Bascom R, Lichtenstein LM, Kagey-Sobotka A, Adkinson NF, Naclerio RM. Experimentally induced nasal allergic responses. J Allergy Clin Immunol 1988;81:940-949.
118. Togias A, Naclerio RM, Proud D, Pipkorn U, Bascom R, Illiopoulos O, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Studies on the allergic and non-allergic nasal inflammation. J Allergy Clin Immunol 1988;81:782-790.
119. Cole P, Havas T. Nasal resistance to respiratory airflow: a plethysmographic alternative to the face mask. Rhinology 1987;25:159-166.
120. Eccles R. Rhinomanometry and nasal challenge. In: Mackay I, ed. Rhinitis: Mechanisms and Management. London: Royal Society of Medicine Services Ltd 1989; pp. 53-67.
121. Schumacher MJ. Advances in tests for evaluation of rhinitis. Immunol Allergy Clinics N Am 1987; 7:15-35.
122. Olsson P, Bende M, Ohlin P. The laser Doppler flowmeter for measuring microcirculation in human nasal mucosa. Acta Otolaryngol (Stockh) 1985;99: 133-139.
123. Hilberg O, Jackson AC, Swift DL, Pederson OF. Acoustic rhinomanometry: evaluation of nasal cavity geometry by acoustic reflexion. J Appl Physiol 1989;66:295-303.
124. Lenders H, Pirsig W. Diagnostic value of acoustic rhinometry: patients with allergic and vasomotor rhinitis compared with normal controls. Rhinology 1990;28:5-16.
125. Pelikan Z, Pelikan-Filipek M, Venmans BJW. Nasal response due to the food ingestion challenge and protective effects of oral disodium cromoglycate (DSCG). Ann Allergy 1988;60:149(abstract 25).
126. Pelikan Z. Effects of Cetirizine (CZ) on the immediate (INR) and late nasal response (LNR) and on the eosinophils in the nasal secretions (NS). J Allergy Clin Immunol 1993;91(No 1, Part 2):193(abstract 210).
127. Pelikan Z. The immediate/early, late and delayed nasal response to allergen challenge, their occurrence and association with various "in vivo" and "in vitro" diagnostic parameters, other organs' responses, and non-specific hyperreactivity, and pharmacologic control. In preparation as a monograph.
128. Pelikan Z, Johansson S-A. The effects of budesonide (BSA) on the late asthmatic response (LAR), administered before and at various points in time after allergen challenge (abstract). Allergy Clin Immunol News 1991;(suppl 1):180.
129. Pelikan Z, Knottnerus I. Inhibition of the late asthmatic response by nedocromil sodium administered more than two hours after allergen challenge. J Allergy Clin Immunol 1993;92:19-28.
130. th International Congress of Allergology and Clinical Immunology. London and Basingstoke: The Macmillan Press Ltd, 1982; Abstract 392P.
131. Fireman P. Allergic rhinitis. In: Bluestone CD, Stool SE, eds. Pediatric Otolaryngology, 2nd ed. Philadelphia: WB Saunders, 1990; pp. 793-804.
132. Pelikan M, Pelikan Z. The role of the nasal mucosa in some cases of allergic conjunctivitis and the effects of disodium cromoglycate (DSCG). J Allergy Clin Immunol 1985;75(No 1, Part 2):186(abstract).
133. Pelikan Z. Changes in middle ear pressure (MEP) due to the nasal allergen challenge in patients with secretory otitis media (SOM) and otalgia. J Allergy Clin Immunol 1987;79:258(abstract).
134. Pelikan Z, Pelikan-Filipek M. Middle ear response due to the food ingestion challenge. J Allergy Clin Immunol 1989;83:239(abstract).
135. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge. Effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-589.
136. Iliopoulos O, Proud D, Adkinson NF, Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Relationship between the early, late and rechallenge reaction to nasal challenge with antigen: observation on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990;86:851-861.
137. Meltzer EO, Orgel AH, Jalowayski A. Cytology. In: Mygind N, Naclerio RM, eds. Allergic and Non-allergic Rhinitis - Clinical Aspects. Copenhagen: Munksgaard, 1993; pp. 66-81.
138. Mygind N, Weeke B, Ullman S. Quantitative determination of immunoglobulins in nasal secretion. Int Arch Allergy 1975;49:99-107.
139. nd ed. Oxford: Blackwell Sci, 1979.
140. Platts-Mills TAE, Mur RK von, Ishizaka K, Norman PS, Lichtenstein LM. IgA and IgG anti-ragweed antibodies in nasal secretions. J Clin Invest 1976;57:1041-1050.
141. Deutschl H, Johansson SGO. Specific IgE antibodies in nasal secretion from patients with allergic rhinitis and with negative or weakly positive RAST in the serum. Clin Allergy 1977;7:195-202.
142. Platts-Mills TAE. Local production of IgG, IgA and IgE antibodies in grasspollen hay fever. J Immunol 1979;122:2218-2225.
143. Houri M, Msyer ALR, Houghton LE, Jacobs D. Correlation of skin, nasal and inhalation tests with IgE in the serum, nasal fluid and sputum. Clin Allergy 1972;2:285-298.
144. Bascom R, Pipkorn U, Proud D, Dunnette S, Gleich GJ, Lichtenstein LM, Naclerio RM. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effects of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol 1989;84:338-346.
145. 4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989;83:634-642.
146. Pelikan Z, Pelikan-Filipek M. Histamine in the serum and the changes in its concentration accompanying the basic types of the nasal mucosa response to allergen challenge. Prepared for the presentation.
147. Brofelt S, Mygind N. Viscosity and spinability of nasal secretions induced by different provocation tests. Am Rev Respir Dis 1987;136:353-356.
148. Raphael GD, Igarashi Y, White MV, Kaliner MA. The pathophysiology of rhinitis. V. Source of protein in allergen-induced nasal secretions. J Allergy Clin Immunol 1991;88:33-42.
149. Lozewicz S, Gomez E, Chalstrey S, Gathland D, Davies RJ. Time course of cellular infiltration in the nasal mucosa during the immediate allergic reaction. Int Arch Allergy Appl Immunol 1991;95:273-277.
150. Small P, Barrett D. Effects of high doses of topical steroids on both ragweed and histamine-induced nasal provocation. Ann Allergy 1991;67:520-524.
151. Ruhno J, Denborg J, Dolovich J. Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis. J Allergy Clin Immunol 1988;81:570-574.
152. Kaulbach HC, Igarashi Y, Mullol J, White MV, Kaliner MA. Effects of nedocromil sodium on allergen-induced rhinitis in humans. J Allergy Clin Immunol 1992;89:599-610.
153. Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretions (NS) during the immediate (INR), late (LNR) and delayed nasal response (DYNR) to allergen challenge and their pharmacologic modulation by various drugs. In preparation for publication.
154. Majchel AM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy 1990;20:701-705.
155. Naclerio RM, Proud D, Kagey-Sabotka A, Freidhoff L, Norman PS, Lichtenstein LM. The effect of cetirizine on early allergic response. Laryngoscope 1989; 99:956-599.
156. Meltzer EO, Schatz M. Pharmacotherapy of rhinitis - 1987 and beyond. Immunol Allergy Clin N Am 1987;7:57-91.
157. 1-receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol 1988;81:975-980.
158. th ed. St. Louis, MO: Mosby-Year Book, 1993; pp. 856-892.
159. Borts MR, Druce HM. The use of intranasal anticholinergic agents in the treatment of non-allergic perennial rhinitis. J Allergy Clin Immunol 1992;90:1065-1070.
160. th ISIAN & combined with BSACI & EAFS, London, June 24-29, 1990;227.
161. Pelikan Z. Nasal secretions cytology during the immediate and late nasal response to allergen challenge. J Allergy Clin Immunol 1989;83(No 1):243(abstract 287).
162. Pelikan Z, Pelikan-Filipek M. Cytological changes in the nasal secretions during the late nasal response. J Allergy Clin Immunol 1986;77(No 1, Part 2):245 (abstract 497).
163. Pelikan Z, Pelikan-Filipek M. Intracellular changes in some cell types in nasal secretions (NS) during the late nasal response (LNR) to allergen challenge (NPT). Clin Exp Allergy 1990;20(suppl 1):60(abstract P 131).
164. Pelikan Z, Pelikan-Filipek M. The antigen-specific IgE antibodies and antibodies of other classes in the nasal secretions (NS) and in the serum, and the changes in their concentrations during the particular types of nasal response (INR, LNR, DYNR) to allergen challenge. In preparation for publication.
165. Pelikan Z, Boorsma M. Effects of intranasal budesonide (BUD) on the early (ENR) and late nasal response (LNR) to challenge (NPT) with bird faeces extracts. J Allergy Clin Immunol 1994;93(No 1, Part 2):165(abstract 14).
166. Bisgaard H, Gronberg H, Mygind N, Dahl R, Lindquist N, Venge P. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990;85:891-895.
167. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis 1988;138:406-412.
168. Pelikan Z, Pelikan-Filipek M. The late asthmatic response to allergen challenge - part I. Ann Allergy 1986;56:414-420.
169. Pelikan Z, Pelikan-Filipek M. The late asthmatic response to allergen challenge - part II. Ann Allergy 1986;56:421-435.
170. Pelikan Z, Pelikan M, Kruis M, Berger MPF. The immediate asthmatic response to allergen challenge. Ann Allergy 1986;56:252-260.
171. Pelikan Z, Pelikan-Filipek M. Cytologic changes in the nasal secretions (NS) during the delayed nasal response to allergen challenge (DNR). Clin Exp Allergy 1990;20(suppl 1):27(abstract P52).
172. Pelikan Z. Delayed asthmatic response and its pharmacologic modulation. J Allergy Clin Immunol 1989;83(No 1):224(abstract 290).
173. Pelikan Z. Delayed asthmatic response (DAR) and its pharmacologic modulation. In: Nijkamp FP, Engels F, Hendricks PAV, Oosterhout AJM, eds. Mediators in Airway Hyperreactivity (suppl 31 to Agents and Actions). Basel, Switzerland: Birkhäuser Verlag 1990; pp. 49-54.
174. Pelikan Z, Pelikan-Filipek M. A new clinical phenomenon - a delayed type of asthmatic response to allergen challenge (DAR) and its pharmacologic modulation. J Allergy Clin Immunol 1991;87(No 1, Part 2):249(abstract 437).
175. Holt PG, McMenamin C, Schon-Hegrad MA, Strickland D, Nelson D, Wilkes L, Bilyk N, Oliver J, Holt BJ, McMenamin PG. Immunoregulation of asthma: control of T-lymphocyte activation in the respiratory tract. Eur Respir J 1991;4(suppl 13):65-159.
176. Enander I, Nygren H, Ahlstedt S. Immunological suppression of delayed hypersensitivity responses in mouse lungs as reflected by numbers of mononuclear cells, mast cells and mucus-producing cells. Int Arch Allergy Appl Immunol 1988;85:99-103.
177. Enander E, Nefgren A, Nygren H, Larsson P, Holmdahl R, Klareskog L, Ahlstedt S. Regulation by T cells delayed hypersensitivity reaction in mouse lung as reflected by mononuclear cells, mast cells and mucus-producing cells. Int Arch Allergy Appl Immunol 1988;85:374-380.
178. Loveren van H, Garssen J, Nijkamp FP. T-cell-mediated airway hyperreactivity in mice. Eur Respir J 1991;4(suppl 13):169-265.
179. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST. Early and late-phase bronchoconstriction after allergen challenge of non-anaesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis 1988;137:548-557.
180. Corrigan CJ, Kay AB. T-lymphocyte activation in acute severe asthma is accompanied by elevated serum concentrations of Gamma-interferon and Interleukin-2 receptor. Clin Exptl Allergy 1990;20(suppl 1):117(abstract S 12/8).
181. Sustiel A, Rocklin RE. T cell responses in allergic rhinitis, asthma and atopic dermatitis. Clin Exp Allergy 1989;19:11-18.
182. Frew AJ, Corrigan CJ, Maestrelli P, Tsai J-J, Kurihara K, O'Hehir RE, Hartnell A, Cromwell O, Kay AB. T-lymphocytes in allergen-induced late-phase reactions and asthma. Int Arch Allergy Appl Immunol 1989;88:63-67.
183. th International Symposium on Infection and Allergy of the Nose & combined with British Society of Allergology and Clinical Immunology & European Association of Facial Surgery, London, June 24-29, 1990;94.
184. Bentley AM, Cumberworth V, Varney VA, Jacobson MR, Sudderick RM, Kay AB, Durham SR. Studies during the pollen season in understanding allergic rhinitis. In: Gordard Ph, Bousquet J, Michel FB, eds. Advances in Allergology and Clinical Immunology. Carnforth, Lancaster, UK: Parthenon 1992; pp. 457-464.
185. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irain AM, Schwartz LB, Mackay IS, Kay AB, Durham SR. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Am Rev Respir Dis 1992;146:170-176.
186. Kapsenberg ML, Jansen HM, Bos JD, Wierenga EA. Role of type 1 and type 2 T-helper cells in allergic diseases. Curr Opinion Immunol 1992;4:788-793.
187. Benner R, Savelkoul HFJ. Regulation of IgE production in mice. Eur Respir J 1991;4(suppl 13):973-1043.
188. Kay AB, Corrigan CJ, Frew AJ. Immunoregulation of asthma: control of T-lymphocyte activation in the respiratory tract. Eur Respir J 1991;4(suppl 13): 1053-1123.
189. Corrigan CJ, Kay AB. Lymphocytes. In: Middleton E Jr, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St. Louis, MO: Mosby-Year Book, 1993; pp. 206-211.
190. Hellquist HB, Karlsson MG, Rudblad S, Ekedahl C, Davisson A. Activated T-cells in the nasal mucosa of patients with grass-pollen allergy. A pilot study. Rhinology 1992;30:57-63.
191. + T cells in allergy. Allergy 1992;47:12-21.
192. Crump JW, Pueringer RJ, Hunninghake GW. Bronchoalveolar lavage and lymphocytes in asthma. Eur Respir J 1991;4(suppl 13):39s-46s.
193. Frew AJ, O'Hehir RE. What can we learn from studies of lymphocytes present in allergic-reaction sites? J Allergy Clin Immunol 1992;89:783-788.
194. Gerblich AA, Salik H, Schnyer MR. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am Rev Respir Dis 1990;141:970-977.
195. Frew AJ, Kay AB. Eosinophils and T-lymphocytes in late-phase allergic reactions. J Allergy Clin Immunol 1990;85:533-539.
196. Brogden RN, Speight TM, Avery GS. Sodium cromoglycate (Cromolyn Sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs 1974;7:188-282.
197. Foreman JC, Pearce FL. Cromolyn and Nedocromil. In: Middleton E Jr, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St. Louis, MO: Mosby-Year Book, 1993; pp. 926-940.
198. ®). Eur Respir J 1986;69(suppl No 147):120-131.
199. Gross NJ, Boushey HA, Gold WM. Anticholinergic drugs. In: Middleton E Jr, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St Louis, MO: Mosby-Year Book, 1993; pp. 941-962.
200. Schleimer RP, Claman HN, Oronsky A. Anti-inflammatory Steroid Action, Basic and General Aspects. San Diego: Academic, 1989.
201. nd ed. New York; Raven, 1992; pp. 1061-1081.
202. Schleimer RP. Glucocorticosteroids, their mechanisms of action and use in allergic diseases. In: Middleton E Jr, Reed ChE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy, Principles and Practice, 4th ed. St Louis, MO: Mosby-Year Book, 1993; pp. 893-925.
203. Gaga M, Frew AJ, Varney VA, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J Immunol 1991;147:816-822.
204. Gonzalez MC, Diaz P, Gallequillos FR, Ancic P, Cromwell O, Kay AB. Allergen-induced recruitment of bronchoalveolor helper (okt 4) and suppressor (okt 8) T-cells in asthma. Am Rev Respir Dis 1987;136:600-604.
205. Pelikan Z. Nasal response to food ingestion challenge. Arch Otolaryngol Head & Neck Surg 1988;114:525-530.
206. Pelikan Z, Pelikan-Filipek M. Effects of oral cromolyn on the nasal response due to foods. Arch Otolaryngol Head & Neck Surg 1989;115:1238-1243.
207. Pelikan Z, Pelikan-Filipek M. Middle ear response due to the food ingestion challenge. J Allergy Clin Immunol 1989;83(No 1):239(abstract 269).
208. Pelikan-Filipek M, Pelikan Z. A comparison of double-blind and open techniques of food ingestion challenge upon recording of objective and subjective parameters. J Allergy Clin Immunol 1994;93(No 1, Part 2):303(abstract 844).
209. Pelikan Z, Pelikan-Filipek M. Bronchial response to the food ingestion challenge. Ann Allergy 1987;58:164-172.
210. Pelikan Z, Pelikan-Filipek M, Knottnerus I. Asthmatic response to food ingestion challenge (FICH) and protective effects of oral cromolyn. Allergy Clin Immunol News 1991;(suppl 1):108(abstract 71).
211. Pelikan-Filipek M, Pelikan Z. Protective effects of oral cromolyn on the immediate and late asthmatic response due to the food ingestion challenge. Allergy 1993;48:113(abstract 2071).
212. Pelikan Z, Pelikan-Filipek M. The involvement of foods in atopic eczema. N Engl Reg Allergy Proc 1988;9(No 4):327.
213. Pelikan Z, Pelikan-Filipek M. Protective effects of oral disodium cromoglycate (DSCG) in atopic eczema due to food ingested. N Engl Reg Allergy Proc 1988;9(No 4):327.
214. ®). Allergy 1992;47(No 12, suppl):50.
215. Pelikan Z, Knottnerus I. Protective effects of oral cromolyn (DSCG) on migraine due to the adverse reactions to foods. J Allergy Clin Immunol 1993;91:(No 1, Part 2):150(abstract 38).
216. Wald ER, Guevra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991;87:129-133.
217. Friday G, Fireman P, Sukanich A, Steinberg M. Sinusitis. In: Naspitz CK, Tinkelman DG, eds. Childhood Rhinitis and Sinusitis. New York: Marcel Dekker, 1990;199-215.
218. Gwaltney JM, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen year experience at the university of Virginia and review of other selected studies. J Allergy Clin Immunol 1992;90:457-462.
219. Zeiger RS. Prospects for ancillary treatment of sinusitis in the 1990s. J Allergy Clin Immunol 1992;90:478-495.
220. Lund VJ. Sinusitis: diagnosis and treatment In: Mackay I, ed. Rhinitis; Mechanisms and Management. London: Royal Society of Medicine Services Ltd, 1989; pp. 153-167.
221. Katz RM, Patnaik M, Siegel S, Rachelefsky G, Corren J, Schanker H, Spector S. The treatment of acute sinusitis in adults. Allergy Clin Immunol News 1994;(suppl No 2):515(abstract 1892).
222. Suonpää J, Suonpää S. The role of nasal allergy in acute frontal sinusitis. N Engl Reg Allergy Proc 1988;9:253(abstract 17).
223. Goldenhersch MJ, Rachelefsky G, Dudley J, Brill J, Katz R, Rohr A, Spector S, Siegel S, Feingold S. Bacteriology of chronic maxillary sinusitis in children with respiratory allergy. J Allergy Clin Immunol 1989;83:214(abstract 170).
224. Pelikan Z, Pelikan-Filipek M. The basic types of the paranasal sinus response to nasal challenge with allergens and non-specific agents, their occurrence, association with various "in vivo" and "in vitro" diagnostic parameters, diagnostic procedure and treatment. In preparation for publication.
225. Draf W, Strasding G. Radiology, ultrasound and endoscopy in the diagnosis of diseases of the nose and paranasal sinuses. In: Mackay I, eds. Rhinitis: Mechanisms and Management, London: Royal Society of Medicine Services Ltd 1989; pp. 81-96.
226. Druce HM. Diagnosis and management of chronic sinusitis and its complications. Immunol Allergy Clinics N Am 1987;7(No 1):117-132.
227. Clement P, Van der Veken P, Iwens P, Buisseret Th. X-ray, CT-scan, MR-imaging. In: Mygind N, Naclerio RM, eds. Allergic and Non-allergic Rhinitis, Clinical Aspects. Copenhagen: Munksgaard, 1993; pp. 58-65.
228. Katz R, Fridman S, Diament M, Rohr A, Siegel S, Rachelefsky G, Spector S. A comparison of sinus imagery in chronic sinusitis. J Allergy Clin Immunol 1989;83:213(abstract 168).
229. Wald ER. Microbiology of acute and chronic sinusitis in children. J Allergy Clin Immunol 1992;90:452-460.
230. Slavin RG. Asthma and sinusitis. J Allergy Clin Immunol 1992;90(No 3, Part 2):518-520.
231. Vinning EM, Kennedy DW. Surgical management in adults. Immunol Allergy Clin N Am 1994;14(No 1):97-111.
232. Reid TE, Shearer WT. Recurrent sinusitis and immunodeficiency. Immunol Allergy Clin N Am 1994;14(No 1):143-170.
233. Richardson MA. Surgical management in children. Immunol Allergy Clin N Am 1994;(No 1):89-95.
234. Evans R. Environmental control and immunotherapy for allergic disease. J Allergy Clin Immunol 1992;90:462-468.
235. Wong DA, Dolovich J. Topical medical management of allergic conditions of the nose. Part 1: Topical medical treatment (excluding intranasal steroids). In: Mackay I, ed. Rhinitis: Mechanisms and Management. London: Royal Society of Medicine Services Ltd, 1989; pp. 169-182.
236. Warner JO. Nasal allergy in children. In: Mackay I, ed. Rhinitis: Mechanisms and Management. London: Royal Society of Medicine Services Ltd, 1989; pp. 215-224.
237. Donnelly AL, Casale TB, Bernstein DI, Goldstein S, Grossman J, Schwartz HJ. Nedocromil sodium 1% nasal solution reduces symptoms of ragweed seasonal allergic rhinitis within 24 hours. J Allergy Clin Immunol 1994;93(No 1, Part 2):272(abstract 659).
238. Cauwenberge van P. The use of systemic corticosteroids in the treatment of rhinitis. In: Mackay I, ed. Rhinitis: Mechanisms and Management. London: Royal Society of Medicine Services, 1989; pp. 199-213.
239. Mackay IS: Topical medical management of allergic conditions of the nose. Part 2: Intranasal steroids. In: Mackay I, ed. Rhinitis: Mechanisms and Management. London: Royal Society of Medicine Services Ltd, 1989; pp. 183-204.
240. Malm L, Änggard A. Vasoconstrictors. In: Mygind N, Naclerio RM, eds. Allergic and Non-Allergic Rhinitis-Clinical Aspects. Copenhagen: Munksgaard, 1993; pp. 95-100.
241. Dolovich J, Mygind N. Anticholinergic medication. In: Mygind N, Naclerio RM, eds. Allergic and Non-Allergic Rhinitis - Clinical Aspects. Copenhagen: Munksgaard, 1993; pp. 105-110.
242. Pelikan Z, Pelikan-Filipek M. Disodium cromoglycate (DSCG)-comparison of 2% and 4% formulations in seasonal allergic rhinitis. Clin Exp Allergy 1990;20 (suppl 1):100(abstract P243).
243. Grieco MH. Diagnosis of upper respiratory tract allergy: classical versus controversial. Immunol Allergy Clin N Am 1987;7:1-13.